These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 24434423
1. Topical delivery of siRNA into skin using SPACE-peptide carriers. Chen M, Zakrewsky M, Gupta V, Anselmo AC, Slee DH, Muraski JA, Mitragotri S. J Control Release; 2014 Apr 10; 179():33-41. PubMed ID: 24434423 [Abstract] [Full Text] [Related]
2. Delivery of siRNA and other macromolecules into skin and cells using a peptide enhancer. Hsu T, Mitragotri S. Proc Natl Acad Sci U S A; 2011 Sep 20; 108(38):15816-21. PubMed ID: 21903933 [Abstract] [Full Text] [Related]
4. Study and Evaluation of the Potential of Lipid Nanocarriers for Transdermal Delivery of siRNA. Lee K, Min D, Choi Y, Kim J, Yoon S, Jang J, Park S, Tanaka M, Cho YW, Koo HJ, Jeon H, Choi J. Biotechnol J; 2020 Dec 20; 15(12):e2000079. PubMed ID: 32678938 [Abstract] [Full Text] [Related]
5. Topical delivery of siRNA into skin using ionic liquids. Dharamdasani V, Mandal A, Qi QM, Suzuki I, Bentley MVLB, Mitragotri S. J Control Release; 2020 Jul 10; 323():475-482. PubMed ID: 32339547 [Abstract] [Full Text] [Related]
6. Development of edge-activated liposomes for siRNA delivery to human basal epidermis for melanoma therapy. Dorrani M, Garbuzenko OB, Minko T, Michniak-Kohn B. J Control Release; 2016 Apr 28; 228():150-158. PubMed ID: 26965957 [Abstract] [Full Text] [Related]
7. Dendrimer as a new potential carrier for topical delivery of siRNA: A comparative study of dendriplex vs. lipoplex for delivery of TNF-α siRNA. Pandi P, Jain A, Kommineni N, Ionov M, Bryszewska M, Khan W. Int J Pharm; 2018 Oct 25; 550(1-2):240-250. PubMed ID: 30165098 [Abstract] [Full Text] [Related]
8. Development of an Innovative Intradermal siRNA Delivery System Using a Combination of a Functional Stearylated Cytoplasm-Responsive Peptide and a Tight Junction-Opening Peptide. Ibaraki H, Kanazawa T, Takashima Y, Okada H, Seta Y. Molecules; 2016 Sep 24; 21(10):. PubMed ID: 27669207 [Abstract] [Full Text] [Related]
9. Development of a Liquid Crystal Formulation that Can Penetrate the Stratum Corneum for Intradermal Delivery of Small Interfering RNA. Kawai M, Ibaraki H, Takashima Y, Kanazawa T, Okada H. Mol Pharm; 2021 Mar 01; 18(3):1038-1047. PubMed ID: 33395310 [Abstract] [Full Text] [Related]
10. Highly efficient delivery of siRNA to a heart transplant model by a novel cell penetrating peptide-dsRNA binding domain. Li H, Zheng X, Koren V, Vashist YK, Tsui TY. Int J Pharm; 2014 Jul 20; 469(1):206-13. PubMed ID: 24768403 [Abstract] [Full Text] [Related]
11. Epidermal cell culture model with tight stratum corneum as a tool for dermal gene delivery studies. Paasonen L, Korhonen M, Yliperttula M, Urtti A. Int J Pharm; 2006 Jan 13; 307(2):188-93. PubMed ID: 16297582 [Abstract] [Full Text] [Related]
12. Skin Delivery of siRNA Using Sponge Spicules in Combination with Cationic Flexible Liposomes. Liang X, Zhang J, Ou H, Chen J, Mitragotri S, Chen M. Mol Ther Nucleic Acids; 2020 Jun 05; 20():639-648. PubMed ID: 32380414 [Abstract] [Full Text] [Related]
13. Liquid crystalline phase nanodispersions enable skin delivery of siRNA. Vicentini FT, Depieri LV, Polizello AC, Del Ciampo JO, Spadaro AC, Fantini MC, Vitória Lopes Badra Bentley M. Eur J Pharm Biopharm; 2013 Jan 05; 83(1):16-24. PubMed ID: 23010565 [Abstract] [Full Text] [Related]
14. An elastic liposomal formulation for RNAi-based topical treatment of skin disorders: Proof-of-concept in the treatment of psoriasis. Desmet E, Bracke S, Forier K, Taevernier L, Stuart MC, De Spiegeleer B, Raemdonck K, Van Gele M, Lambert J. Int J Pharm; 2016 Mar 16; 500(1-2):268-74. PubMed ID: 26806466 [Abstract] [Full Text] [Related]
15. DOTAP functionalizing single-walled carbon nanotubes as non-viral vectors for efficient intracellular siRNA delivery. Li H, Hao Y, Wang N, Wang L, Jia S, Wang Y, Yang L, Zhang Y, Zhang Z. Drug Deliv; 2016 Mar 16; 23(3):840-8. PubMed ID: 24892622 [Abstract] [Full Text] [Related]
16. Development of an efficient transdermal delivery system of small interfering RNA using functional peptides, Tat and AT-1002. Uchida T, Kanazawa T, Takashima Y, Okada H. Chem Pharm Bull (Tokyo); 2011 Mar 16; 59(2):196-201. PubMed ID: 21297299 [Abstract] [Full Text] [Related]
17. Topical and Targeted Delivery of siRNAs to Melanoma Cells Using a Fusion Peptide Carrier. Ruan R, Chen M, Sun S, Wei P, Zou L, Liu J, Gao D, Wen L, Ding W. Sci Rep; 2016 Jul 04; 6():29159. PubMed ID: 27374619 [Abstract] [Full Text] [Related]
18. RNAi mediated IL-6 in vitro knockdown in psoriasis skin model with topical siRNA delivery system based on liquid crystalline phase. Depieri LV, Borgheti-Cardoso LN, Campos PM, Otaguiri KK, Vicentini FT, Lopes LB, Fonseca MJ, Bentley MV. Eur J Pharm Biopharm; 2016 Aug 04; 105():50-8. PubMed ID: 27224855 [Abstract] [Full Text] [Related]
19. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing. Cardoso AL, Simões S, de Almeida LP, Pelisek J, Culmsee C, Wagner E, Pedroso de Lima MC. J Gene Med; 2007 Mar 04; 9(3):170-83. PubMed ID: 17351968 [Abstract] [Full Text] [Related]